The global econsent in healthcare market is anticipated to grow at a CAGR of 9. 90% during the forecast period (2023-2030). EConsent platforms are used in a variety of settings, including clinical trials and research studies, hospital and healthcare facilities, telemedicine and remote consultations, patient onboarding and registration, health information exchange, and mobile healthcare applications. These platforms facilitate the collection and management of consent electronically from participants, ensuring compliance with regulatory standards. Additionally, they enable patients to provide consent electronically for sharing their medical information among healthcare providers, in addition for the virtual consultations, prescriptions, and remote treatments. The market’s growth is attributed to technology advancements. The rapid advancement of technology has made electronic solutions more accessible, cost-effective, and efficient, pushing the implementation of eConsent solutions in healthcare settings. For instance, in October 2023, Mednet, released featuring electronic consent capabilities (eConsent) within the iMednet eClinical platform. The new eConsent module was developed to provide a simple, cost-effective, and compliant method of gathering and organizing participant consent to satisfy the needs of hybrid, virtual, and decentralized clinical trials, in addition to assist the drive for more participant variety.
Browse the full report description of “EConsent in Healthcare Market Size, Share & Trends Analysis Report by Enrollment Type (On-site, and Remote Consent), by Deployment Mode (Cloud-based, and Web-based) and by Form Type (General Consent, General Consent with Specific Denial(s), General Denial with Specific Consent(s), and General Denial), Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/econsent-in-healthcare-market
Furthermore, clinical trials are evolving to include more decentralized and hybrid models. This requires consent management solutions that are adaptable and compliant. EConsent platforms enable remote participation and patient engagement that fits with these new trial methodologies. In January 2022, SMART-TRIAL released version 2022.1, that includes the brand new Add-On, eConsent, In addition to a few minor adjustments and changes.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Enrollment Type
o By Deployment Mode
o By Form Type
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes Magentus Group Pty Ltd., Medable, Inc., Medrio, Inc., ObvioHealth, and Veeva Systems and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global EConsent in Healthcare Market Report Segment
By Enrollment Type
By Deployment Mode
By Form Type
Global EConsent in Healthcare Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/econsent-in-healthcare-market